Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 227-231 , March 2006

Blood group antigenicity and clinical durability of cryopreserved homografts

References 

  1. Murray G. Homologous aortic valve segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology. 1956;7:466–471
  2. Hopkins RA, St. Louis J, Corcoran PC. Ross' first homograft replacement of the aortic valve. Ann Thorac Surg. 1991;52:1190–1193
  3. Barratt-Boyes BG. Homograft aortic valve replacement and aortic incompetence and stenosis. Thorax. 1964;19:131–150
  4. Ross DN, Somerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet. 1966;2:521–527
  5. Stark J. The use of valved conduits in pediatric cardiac surgery. Pediatr Cardiol. 1998;19:282–288
  6. Merin G, McGoon DC. Reoperation after insertion of aortic homograft as right ventricular outflow tract. Ann Thorac Surg. 1973;16:122–126
  7. Bowman FO, Hancock WD, Malm JR. A valve-containing Dacron prosthesis. Its use in restoring pulmonary artery–right ventricular continuity. Arch Surg. 1973;724–728
  8. Agarwal KC, Edwards WD, Feldt RH. Pathogenesis of nonobstructive fibrous peels in right-valved extra-cardiac conduits. J Thorac Cardiovasc Surg. 1982;83:584–589
  9. McNally R, Barwick R, Smith-Morse B, Rhodes P. Actuarial analysis of a uniform and reliable preservation method for viable heart valve allografts. Ann Thorac Surg. 1989;48:583–584
  10. O'Brien MF, Stafford EG, Gardner MAH, Pohlner PG, McGriffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg. 1987;94:812–823
  11. Hopkins RA, Reyes A, Imperato DA, Carpenter GA, Myers JL, Murphy KA. Ventricular outflow tract reconstructions with cryopreserved cardiac valve homografts. A single surgeon's 10 year experience. Ann Surg. 1996;223:544–554
  12. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovascular Surg. 1995;109:509–518
  13. Hawkins JA, Bailey WW, Dillon T, Schwartz DC. Midterm results with cryopreserved allograft valved conduits from the right ventricle to the pulmonary arteries. J Thorac Cardiovasc Surg. 1992;104:910–916
  14. Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg. 1999;117:141–147
  15. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 2000;102(Suppl III):III-130–III-135
  16. Chan KC, Fyfe DA, McKay CA, Sade RM, Crawford FA. Right ventricular outflow tract reconstruction with cryopreserved homografts in pediatric patients: intermediate-term follow-up with serial echocardiographic assessment. J Am Coll Cardiol. 1994;24:483–489
  17. Schorn K, Yankah AC, Alexi-Meskhishvilli VA, Weng Y, Lange PE, Hetzer R. Risk factors for early degeneration of allografts in pulmonary circulation. Eur J Cardio Thorac Surg. 1997;11:62–69
  18. Santini F, Piccin C, Prioli A, Pessotto R, Mazzucco A. Accelerated aortic allograft fibrocalcification after right ventricular outflow tract reconstruction in pediatric patients: report of two cases. Eur J Cardio Thorac Surg. 1996;10:290–293
  19. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 1993;105:934–943
  20. Baskett RJ, Ross DB, Nanton MA, Murphy DA. Factors in early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?. J Thorac Cardiovasc Surg. 1996;112:1170–1179
  21. Pacifico AD, Kirklin JW, Blackstone EH. Surgical management of pulmonary stenosis in tetralogy of Fallot. J Thorac Cardiovasc Surg. 1977;74:382–395
  22. Shaddy RE, Hawkins JA. Immunology and failure of valved allografts in children. Ann Thorac Surg. 2002;7:1271–1275
  23. Lupinetti FM, Cobb KC, Kioshocs HC, Thompson SA, Walters KS, Moore KC. Effect of immunological differences on rat aortic valve allograft calcification. J Cardiac Surg. 1992;7:65–70
  24. Stark J, Bull C, Stajevic M, Jothi M, de Leval Elliot M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg. 1998;115:506–516
  25. Bull C, MacCarthney FJ, Horvath P, et al. Evaluation of long-term results of homograft and heterograft valves in extracardiac conduits. J Thorac Cardiovasc Surg. 1987;94:12–19
  26. Albert JD, Bishop DA, Fullerton DA, Campbell DN, Clarke DR. Conduit reconstruction of the right ventricular outflow tract: lessons learned in a twelve-year experience. J Thorac Cardiovasc Surg. 1993;106:228–236
  27. Rajani B, Mee RB, Ratcliff NB. Evidence of rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111–117
  28. Balch CM, Karp RB. Blood group compatibility and aortic valve allotransplantation in man. J Thorac Cardiovasc Surg. 1975;70:256–259
  29. Green MK, Walsh MD, Dare A, et al. Histologic and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg. 1998;66:S216;[Suppl]
  30. Moustapha A, Ross DB, Bittira B, et al. Aortic valve grafts in the rat: evidence for rejection. J Thorac Cardiovasc Surg. 1997;114:891–902
  31. Crescenzo DG, Hilbert SL, Barrick MK, et al. Donor heart valves: electron microscopic and morphometric assessment of cellular injury induced by warm ischemia. J Thorac Cardiovasc Surg. 1992;103:253–258
  32. Niwaya K, Sakaguchi H, Kawachi K, Kitamura S. Effect of warm ischemia and cryopreservation on cell viability of human allograft valves. Ann Thorac Surg. 1995;60:S114;[Suppl]
  33. Shaddy RE, Tani LY, Sturtevant JE, Lambert LM, McCough EC. Effects of homograft blood type and anatomic type of stenosis, regurgitation and calcium in homografts in the pulmonary position. Am J Cardiol. 1992;70:392–393
  34. Ross DB, Hamilton GR, Wright JR, Lee TDG. Letter to the editor. Homograft valve failure in children. J Thorac Cardiovasc Surg. 1999;117:1044
  35. Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A. Blood group incompatibility an accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg. 2004;127:242–250
  36. Yankah AC, Wottge HU, Muller-Hermelink HK, et al. Transplantation of aortic and pulmonary allografts. Enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J Card Surg. 1987;2(1 Suppl):209–220
  37. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg. 2003;75:399–411
  38. Hawkins JA, Breinholt JP, Lambert LM, Fuller TC, Profaizer T, McGough EC, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119:324–330
  39. Kadner A, Chen RH, Mitchell RN, Adams DH. Homograft crossmatching is unnecessary due to the absence of blood group antigens. Ann Thorac Surg. 2001;71:S349;[Suppl]
  40. Fishlein T, Schultz A, Haushofer M, et al. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg. 1995;60:S122;[Suppl]
  41. Elkins RC, Lane MM, Capps SB, et al. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg. 2001;13(Suppl 1):82
  42. Shaddy RE, Lambert LM, Fuller TC, Profaizer T, Thompson DD, Baker SI, et al. Prospective randomized trial of azothioprine in cryopreserved valved homografts in children. Ann Thorac Surg. 2001;71:43–47

PII: S1058-9813(05)00089-5

doi: 10.1016/j.ppedcard.2005.11.009

Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 227-231 , March 2006

Article Tools